|
1
|
Saracci R and Wild CP: Fifty years of the
international agency for research on cancer (1965 to 2015). Int J
Cancer. 138:1309–1311. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Inamura K, Fujiwara T, Hoshida Y, Isagawa
T, Jones MH, Virtanen C, Shimane M, Satoh Y, Okumura S, Nakagawa K,
et al: Two subclasses of lung squamous cell carcinoma with
different gene expression profiles and prognosis identified by
hierarchical clustering and non-negative matrix factorization.
Oncogene. 24:7105–7113. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li S, Huang S and Peng SB: Overexpression
of G protein-coupled receptors in cancer cells: Involvement in
tumor progression. Int J Oncol. 27:1329–1339. 2005.PubMed/NCBI
|
|
4
|
Suzuki K, Nagai K, Yoshida J, Nishimura M,
Takahashi K, Yokose T and Nishiwaki Y: Conventional
clinicopathologic prognostic factors in surgically resected
nonsmall cell lung carcinoma. A comparison of prognostic factors
for each pathologic TNM stage based on multivariate analyses.
Cancer. 86:1976–1984. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cancer Genome Atlas Research Network:
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Imielinski M, Berger AH, Hammerman PS,
Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M,
Sivachenko A, et al: Mapping the hallmarks of lung adenocarcinoma
with massively parallel sequencing. Cell. 150:1107–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization of squamous cell lung
cancers. Nature. 489:519–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shaw AT, Kim DW, Nakagawa K, Seto T, Crinó
L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, et al:
Crizotinib versus chemotherapy in advanced ALK-positive lung
cancer. N Engl J Med. 368:2385–2394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mok TS, Wu YL, Thongprasert S, Yang CH,
Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ichinose Y, et
al: Gefitinib or carboplatin-paclitaxel in pulmonary
adenocarcinoma. N Engl J Med. 361:947–957. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
St Laurent G, Wahlestedt C and Kapranov P:
The landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bassett AR, Akhtar A, Barlow DP, Bird AP,
Brockdorff N, Duboule D, Ephrussi A, Ferguson-Smith AC, Gingeras
TR, Haerty W, et al: Considerations when investigating lncRNA
function in vivo. Elife. 3:e030582014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiu M, Xu Y, Wang J, Zhang E, Sun M, Zheng
Y, Li M, Xia W, Feng D, Yin R and Xu L: A novel lncRNA, LUADT1,
promotes lung adenocarcinoma proliferation via the epigenetic
suppression of p27. Cell Death Dis. 6:e18582015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu H, Zhao X, Xiang J, Zhang J, Meng C,
Zhang J, Li M, Song X and Lv C: Interaction network of coexpressed
mRNA, miRNA, and lncRNA activated by TGF-β1 regulates EMT in human
pulmonary epithelial cell. Mol Med Rep. 16:8045–8054. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shalgi R, Lieber D, Oren M and Pilpel Y:
Global and local architecture of the mammalian
microRNA-transcription factor regulatory network. PLoS Comput Biol.
3:e1312007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao
Z, Zhi H, Wang T, Guo Z and Li X: Identification of
lncRNA-associated competing triplets reveals global patterns and
prognostic markers for cancer. Nucleic Acids Res. 43:3478–3489.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kersey PJ, Lawson D, Birney E, Derwent PS,
Haimel M, Herrero J, Keenan S, Kerhornou A, Koscielny G, Kähäri A,
et al: Ensembl Genomes: extending Ensembl across the taxonomic
space. Nucleic Acids Res. 38:(Database Issue). D563–D569. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:(Database Issue). D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ning S, Zhao Z, Ye J, Wang P, Zhi H, Li R,
Wang T, Wang J, Wang L and Li X: SNP@lincTFBS: An integrated
database of polymorphisms in human LincRNA transcription factor
binding sites. PLoS One. 9:e1038512014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Lu M, Qiu C and Cui Q: TransmiR: A
transcription factor-microRNA regulation database. Nucleic Acids
Res. 38:(Database Issue). D119–D122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aerts S, Lambrechts D, Maity S, Van Loo P,
Coessens B, De Smet F, Tranchevent LC, De Moor B, Marynen P, Hassan
B, et al: Gene prioritization through genomic data fusion. Nat
Biotechnol. 24:537–544. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuleshov MV, Jones MR, Rouillard AD,
Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM,
Lachmann A, et al: Enrichr: A comprehensive gene set enrichment
analysis web server 2016 update. Nucleic Acids Res. 44:W90–W97.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X, Wang S, Meng F, Wang J, Zhang Y,
Dai E, Yu X, Li X and Jiang W: SM2miR: A database of the
experimentally validated small molecules' effects on microRNA
expression. Bioinformatics. 29:409–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Amaral LA, Scala A, Barthelemy M and
Stanley HE: Classes of small-world networks. Proc Natl Acad Sci
USA. 97:11149–11152. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanwal M, Ding XJ, Ma ZH, Li LW, Wang P,
Chen Y, Huang YC and Cao Y: Characterization of germline mutations
in familial lung cancer from the Chinese population. Gene.
641:94–104. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumar MS, Erkeland SJ, Pester RE, Chen CY,
Ebert MS, Sharp PA and Jacks T: Suppression of non-small cell lung
tumor development by the let-7 microRNA family. Proc Natl Acad Sci
USA. 105:3903–3908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang E, Li W, Yin D, De W, Zhu L, Sun S
and Han L: c-Myc-regulated long non-coding RNA H19 indicates a poor
prognosis and affects cell proliferation in non-small-cell lung
cancer. Tumour Biol. 37:4007–4015. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kosaka T, Yatabe Y, Endoh H, Kuwano H,
Takahashi T and Mitsudomi T: Mutations of the epidermal growth
factor receptor gene in lung cancer: Biological and clinical
implications. Cancer Res. 64:8919–8923. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yongchun Z, Linwei T, Xicai W, Lianhua Y,
Guangqiang Z, Ming Y, Guanjian L, Yujie L and Yunchao H:
MicroRNA-195 inhibits non-small cell lung cancer cell
proliferation, migration and invasion by targeting MYB. Cancer
Lett. 347:65–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei P, Zhang N, Wang Y, Li D, Wang L, Sun
X, Shen C, Yang Y, Zhou X and Du X: FOXM1 promotes lung
adenocarcinoma invasion and metastasis by upregulating SNAIL. Int J
Biol Sci. 11:186–198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guittat L, Alberti P, Gomez D, De Cian A,
Pennarun G, Lemarteleur T, Belmokhtar C, Paterski R, Morjani H,
Trentesaux C, et al: Targeting human telomerase for cancer
therapeutics. Cytotechnology. 45:75–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Downward J: Targeting RAS signalling
pathways in cancer therapy. Nat Rev Cancer. 3:11–22. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sebolt-Leopold JS: Advances in the
development of cancer therapeutics directed against the
RAS-mitogen-activated protein kinase pathway. Clin Cancer Res.
14:3651–3656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takada M, Fukuoka M, Kawahara M, Sugiura
T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T,
et al: Phase III study of concurrent versus sequential thoracic
radiotherapy in combination with cisplatin and etoposide for
limited-stage small-cell lung cancer: Results of the Japan clinical
oncology group study 9104. J Clin Oncol. 20:3054–3060. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lü JM, Yao Q and Chen C: Ginseng
compounds: An update on their molecular mechanisms and medical
applications. Curr Vasc Pharmacol. 7:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen X, Xie D, Wang L, Zhao Q, You ZH and
Liu H: BNPMDA: BNPMDA: Bipartite network projection for
MiRNA-disease association prediction. Bioinformatics. 34:3178–3186.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen X, Yan CC, Zhang X and You ZH: Long
non-coding RNAs and complex diseases: From experimental results to
computational models. Brief Bioinform. 18:558–576. 2017.PubMed/NCBI
|
|
39
|
Jiang W, Mitra R, Lin CC, Wang Q, Cheng F
and Zhao Z: Systematic dissection of dysregulated transcription
factor-miRNA feed-forward loops across tumor types. Brief
Bioinform. 17:996–1008. 2016. View Article : Google Scholar : PubMed/NCBI
|
